Cargando…
Delayed and limited administration of the JAKinib tofacitinib mitigates chronic DSS-induced colitis
In inflammatory bowel disease, dysregulated T cells express pro-inflammatory cytokines. Using a chronic azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis model resembling ulcerative colitis, we evaluated whether and when treatment with the Janus kinase (JAK) inhibitor tofacitinib could...
Autores principales: | Seal, Rishav, Schwab, Lara S. U., Chiarolla, Cristina M., Hundhausen, Nadine, Klose, Georg Heinrich, Reu-Hofer, Simone, Rosenwald, Andreas, Wiest, Johannes, Berberich-Siebelt, Friederike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235777/ https://www.ncbi.nlm.nih.gov/pubmed/37275854 http://dx.doi.org/10.3389/fimmu.2023.1179311 |
Ejemplares similares
-
Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9(+) T Cells
por: Majumder, Snigdha, et al.
Publicado: (2021) -
NFATc1/αA and Blimp-1 Support the Follicular and Effector Phenotype of Tregs
por: Koenig, Anika, et al.
Publicado: (2022) -
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
por: T. Virtanen, Anniina, et al.
Publicado: (2019) -
Engineered protein and Jakinib nanoplatform with extraordinary rheumatoid arthritis treatment
por: Li, Yuanxin, et al.
Publicado: (2023) -
Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells
por: Bell, Luisa, et al.
Publicado: (2020)